Farabi Pharmaceutical (XTEH:DFRB1) OCF Yield %: 0.00 (As of Jul. 06, 2026)


What is Farabi Pharmaceutical OCF Yield %?

Farabi Pharmaceutical XTEH:DFRB1 OCF Yield % is 0.00 as of Jul. 06, 2026.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Farabi Pharmaceutical's Trailing 12-Month Cash Flow from Operations is IRR0.00 Mil, and Market Cap is IRR0.00 Mil. Therefore, Farabi Pharmaceutical's OCF Yield % for today is 0.00%.

The historical rank and industry rank for Farabi Pharmaceutical's OCF Yield % or its related term are showing as below:


XTEH:DFRB1's OCF Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.41
* Ranked among companies with meaningful OCF Yield % only.

Farabi Pharmaceutical's OCF Margin % for the quarter that ended in . 20 was %.

Farabi Pharmaceutical OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Farabi Pharmaceutical OCF Yield % Related Terms

Farabi Pharmaceutical OCF Yield % Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical OCF Yield % Chart

Farabi Pharmaceutical Annual Data
Trend
OCF Yield %

Farabi Pharmaceutical Quarterly Data
OCF Yield %

Farabi Pharmaceutical OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Farabi Pharmaceutical's OCF Yield % for the fiscal year that ended in . 20 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
= /
=N/A%

Farabi Pharmaceutical's annualized OCF Yield % for the quarter that ended in . 20 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
= * 4 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a OCF Yield % of 0.00 as of Jul. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's OCF Yield % too high?
Farabi Pharmaceutical's current OCF Yield % is 0.00.
How does Farabi Pharmaceutical's OCF Yield % compare to IMNPQ and INNV?
Farabi Pharmaceutical's OCF Yield % of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median OCF Yield % is 3.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.41, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Farabi Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farabi Pharmaceutical's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current OCF Yield % is 0.00 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.